文献速递临床试验与 GCP真实世界研究与卫生经济

数字认知行为疗法用于胰腺炎疼痛管理:IMPACT-2混合效果-实施试验方案

Digital cognitive-behavioral therapy for pain management in individuals with recurrent acute and chronic pancreatitis (IMPACT-2): study protocol for a hybrid effectiveness-implementation trial.
PubMed 文献 · Trials · 2026-02-09

IMPACT-2是一项多中心务实临床试验,计划招募280名伴有慢性疼痛的复发性急性或慢性胰腺炎成人,1:1随机接受数字认知行为疗法或数字疼痛教育,评估疼痛干扰与严重程度等结局,并收集实施数据。

要点

  • 数字CBT组学习放松、活动节奏、目标设定等疼痛自我管理技能。
  • 主要结局为疼痛干扰和严重程度,随访至6个月。
  • 试验依托CPDPC九家临床中心招募并纳入利益相关者参与过程评价。

核心结论

  • IMPACT-2旨在验证数字CBT在复发性急性及慢性胰腺炎疼痛管理中的有效性,并为未来实施提供数据。

研究设计与样本

  • 多中心、务实性混合效果-实施临床试验,计划招募280名18岁以上复发性急性或慢性胰腺炎伴慢性疼痛成人。
  • 参与者按1:1随机分配至数字CBT组或数字疼痛教育组,在基线、2个月和6个月随访评估。
  • 依托NIH资助的CPDPC U01联盟九家临床中心及社区自我转诊招募,利益相关者参与过程评价。

临床怎么用

  • 若试验成功,可为复发性急性及慢性胰腺炎患者提供低成本、可及的非药物疼痛自我管理方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Abdominal pain is a cardinal symptom of pancreatitis, present in up to 90% of patients with recurrent acute pancreatitis (RAP) and chronic pancreatitis (CP). Increases in pain severity and constancy are associated with significant morbidity including depression and anxiety symptoms, low physical functioning, sleep disturbance, and low quality of life, as well as high economic and societal burden. Our pilot study of digital cognitive-behavioral therapy (CBT) demonstrated preliminary efficacy in improving pain and disability in adults with recurrent acute and chronic pancreatitis pain. Building on these promising findings, this hybrid effectiveness-implementation clinical trial seeks to test the effectiveness of digital CBT in a large sample and to gather data on future implementation of this scalable intervention. METHODS: This multisite, pragmatic clinical trial is recruiting 280 adults (ages 18 +) with recurrent acute or chronic pancreatitis who report chronic pain. Participants are randomized 1:1 respectively to one of two groups: (1) Digital CBT, providing access to the Pancreatitis Pain Course to learn pain self-management skills (e.g., relaxation, activity pacing, goal setting), or (2) Digital Pain Education (access to education website about pancreatitis pain). Evaluations are completed at baseline, 2 months, and 6 months follow up. This study leverages resources of the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC), a NIH-sponsored U01 consortium, with recruitment from their nine clinical centers and from self-referral in the community through partnerships with community-based and clinical organizations. Relevant stakeholder groups (patients, providers, organizational managers) will participate in a process evaluation to inform future implementation in clinic and community settings. Primary effectiveness outcomes are pain interference and severity. Secondary outcomes include opioid use, depression, anxiety, quality of life, and sleep. DISCUSSION: Findings from the IMPACT-2 trial will significantly advance solutions for non-pharmacological pain management in RAP and CP. If successful, our project will address a critical need for low-cost, accessible pain self-management. TRIAL REGISTRATION: NCT06386224 ; first posted: 04-26-2024.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Palermo TM, Ohls O, Dear B, et al. Digital cognitive-behavioral therapy for pain management in individuals with recurrent acute and chronic pancreatitis (IMPACT-2): study protocol for a hybrid effectiveness-implementation trial. Trials. 2026. PMID: 41664170. doi:10.1186/s13063-026-09517-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。